Company research
Hims & Hers Health, Inc.
CIK 1773751Updated Sep 25, 2026
HIMS price & chart
Loading TradingView…
NYSE:HIMS on TradingView ↗About the company
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health.
In the news
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS ↗
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – HIMS ↗
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 2,154,705,000Source | 707,539,000Source | 441,186,000Source | 366,341,000Source |
| Property, Plant and Equipment, NetUSD | — | — | — | 3,000,000Source |
| GoodwillUSD | 278,325,000Source | 112,728,000Source | 110,881,000Source | 110,881,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 196,116,000Source | 43,410,000Source | 18,574,000Source | 21,841,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 228,616,000Source | 220,584,000Source | 96,663,000Source | 46,772,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 32,100,000Source | 6,100,000Source | 6,700,000Source | 3,900,000Source |
| Inventory, NetUSD | 80,128,000Source | 64,427,000Source | 22,464,000Source | 21,562,000Source |
| Assets, CurrentUSD | 767,638,000Source | 395,831,000Source | 265,053,000Source | 216,595,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 110,018,000Source | 31,153,000Source | 21,608,000Source | 15,408,000Source |
| Operating Lease, Right-of-Use AssetUSD | 137,046,000Source | 10,881,000Source | 9,588,000Source | 4,936,000Source |
| Other Assets, NoncurrentUSD | 29,680,000Source | 147,000Source | 91,000Source | 11,232,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 1,613,777,000Source | 230,823,000Source | 97,157,000Source | 54,600,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 23,000Source | 22,000Source | 21,000Source | 21,000Source |
| Retained Earnings (Accumulated Deficit)USD | -113,772,000Source | -242,137,000Source | -368,175,000Source | -344,629,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 2,294,000Source | -324,000Source | -124,000Source | -277,000Source |
| Stockholders' Equity Attributable to ParentUSD | 540,928,000Source | 476,716,000Source | 344,029,000Source | 311,741,000Source |
| Additional Paid in Capital, Common StockUSD | 652,383,000Source | 719,155,000Source | 712,307,000Source | 656,626,000Source |
| Liabilities and EquityUSD | 2,154,705,000Source | 707,539,000Source | 441,186,000Source | 366,341,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 404,431,000Source | 221,367,000Source | 88,468,000Source | 47,941,000Source |
| Operating Lease, Liability, CurrentUSD | 4,843,000Source | 1,889,000Source | 1,281,000Source | 1,658,000Source |
| Accounts Payable, CurrentUSD | 143,278,000Source | 91,180,000Source | 43,070,000Source | 32,363,000Source |
| Operating Lease, Liability, NoncurrentUSD | 143,167,000Source | 9,456,000Source | 8,667,000Source | 3,649,000Source |
| Deferred Income Tax Liabilities, NetUSD | 28,856,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | 11,734,000Source | 0Source | 22,000Source | 35,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 78,518,000Source | 53,013,000Source | 28,972,000Source | 12,448,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | 22,000Source | 35,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 54,502,000Source | 17,088,000Source | 9,515,000Source | 7,474,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 135,244,000Source | 92,322,000Source | 66,080,000Source | 42,817,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 13,722,000Source | 41,612,000Source | 902,000Source | 8,004,000Source |
| Increase (Decrease) in Accounts PayableUSD | 30,297,000Source | 43,710,000Source | 7,324,000Source | 12,723,000Source |
| Deferred Income Tax Expense (Benefit)USD | -12,961,000Source | -61,649,000Source | -13,000Source | -594,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 300,006,000Source | 251,084,000Source | 73,483,000Source | -26,531,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 145,227,000Source | 15,399,000Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,024,958,000Source | -19,048,000Source | -12,106,000Source | 34,699,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 116,669,000Source | 52,501,000Source | 14,096,000Source | 3,901,000Source |
| Payments for Repurchase of Common StockUSD | 89,960,000Source | 83,039,000Source | 1,999,000Source | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 729,620,000Source | -107,845,000Source | -11,475,000Source | -33,127,000Source |
| Repayments of Long-term DebtUSD | — | — | — | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 7,176,000Source | 123,921,000Source | 49,891,000Source | -25,012,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 228,616,000Source | 221,440,000Source | 97,519,000Source | 47,628,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | 0Source |
| Income Taxes Paid, NetUSD | 23,162,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,508,000Source | -270,000Source | -11,000Source | -53,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 135,244,000Source | 92,322,000Source | 66,080,000Source | 42,817,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | 0Source | 0Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 4,529,000Source | — | — | — |
| Amortization of Intangible AssetsUSD | 23,700,000Source | 3,800,000Source | 3,500,000Source | 4,100,000Source |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | 4,437,000Source | — | — | — |
| General and Administrative ExpenseUSD | 272,724,000Source | 167,767,000Source | 129,883,000Source | 98,192,000Source |
| GoodwillUSD | 278,325,000Source | 112,728,000Source | 110,881,000Source | 110,881,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 0Source | 0Source | 700,000Source |
| Income Tax Expense (Benefit)USD | -4,441,000Source | -54,327,000Source | 1,975,000Source | -31,000Source |
| Net Income (Loss) Attributable to ParentUSD | 128,365,000Source | 126,038,000Source | -23,546,000Source | -65,678,000Source |
| Noncash Merger Related CostsUSD | 5,893,000Source | 0Source | 2,691,000Source | 837,000Source |
| Nonoperating Income (Expense)USD | 18,311,000Source | 9,808,000Source | 7,882,000Source | 2,988,000Source |
| Operating ExpensesUSD | 1,627,765,000Source | 1,111,232,000Source | 744,402,000Source | 477,419,000Source |
| Other Nonoperating Income (Expense)USD | 23,129,000Source | 9,808,000Source | 8,957,000Source | 2,918,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 108,698,000Source | 208,940,000Source | 170,051,000Source | 194,259,000Source |
| Proceeds from Stock Options ExercisedUSD | 11,033,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 2,347,637,000Source | 1,476,514,000Source | 872,000,000Source | 526,916,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | 105,613,000Source | 61,903,000Source | -29,453,000Source | -68,697,000Source |
| Other Nonoperating Income (Expense)USD | 23,129,000Source | 9,808,000Source | 8,957,000Source | 2,918,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 123,924,000Source | 71,711,000Source | -21,571,000Source | -65,709,000Source |
| Income Tax Expense (Benefit)USD | -4,441,000Source | -54,327,000Source | 1,975,000Source | -31,000Source |
| Net Income (Loss) Attributable to ParentUSD | 128,365,000Source | 126,038,000Source | -23,546,000Source | -65,678,000Source |
| Earnings Per Share, BasicUSD per share | 0.57Source | 0.58Source | -0.11Source | -0.32Source |
| Earnings Per Share, DilutedUSD per share | 0.51Source | 0.53Source | -0.11Source | -0.32Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 224,959,268Source | 215,939,037Source | 209,344,712Source | 204,516,120Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 258,230,547Source | 236,808,876Source | 209,344,712Source | 204,516,120Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 23,700,000Source | 3,800,000Source | 3,500,000Source | 4,100,000Source |
| Current Income Tax Expense (Benefit)USD | 8,520,000Source | 7,322,000Source | 1,988,000Source | 563,000Source |
| General and Administrative ExpenseUSD | 272,724,000Source | 167,767,000Source | 129,883,000Source | 98,192,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | 1,733,378,000Source | 1,173,135,000Source | 714,949,000Source | 408,722,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 134,183,000Source | 71,111,000Source | -16,749,000Source | -62,539,000Source |
| Nonoperating Income (Expense)USD | 18,311,000Source | 9,808,000Source | 7,882,000Source | 2,988,000Source |
| Operating ExpensesUSD | 1,627,765,000Source | 1,111,232,000Source | 744,402,000Source | 477,419,000Source |
Filing attachments
d264371dex41.htm · 8-K · 2026-05-21
EX-4.1 2 d264371dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 Execution Version HIMS & HERS HEALTH, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of May 21, 2026 0.00% Convertible Senior Notes due 2032 TABLE OF CONTENTS Page Article 1. Definitions; Ru…
Read attachment ↗d227898dex991.htm · 8-K · 2026-05-19
EX-99.1 2 d227898dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment Proceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its international expansion strategy, including the proposed acquisition of Eucalyptus, invests in technology and operational infrastructure to drive anticipated cost efficiencies, and en…
Read attachment ↗d227898dex992.htm · 8-K · 2026-05-19
EX-99.2 3 d227898dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment Proceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its international expansion strategy, including the proposed acquisition of Eucalyptus, invests in technology and operational infrastructure to drive anticipated cost efficiencies…
Read attachment ↗